Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
45.46
-0.14 (-0.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Exact Sciences Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for Exact Sciences stock have an average target of 68.95, with a low estimate of 52 and a high estimate of 90. The average target predicts an increase of 51.67% from the current stock price of 45.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exact Sciences stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 10 | 10 | 10 | 11 |
| Buy | 6 | 5 | 6 | 6 | 6 | 7 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 18 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +31.98% | Apr 11, 2025 |
| Barclays | Barclays | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +20.99% | Apr 10, 2025 |
| Mizuho | Mizuho | Buy Initiates $60 | Buy | Initiates | $60 | +31.98% | Apr 10, 2025 |
| RBC Capital | RBC Capital | Hold Initiates $52 | Hold | Initiates | $52 | +14.39% | Mar 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $75 → $70 | Buy | Maintains | $75 → $70 | +53.98% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
3.12B
from 2.76B
Increased by 12.98%
Revenue Next Year
3.52B
from 3.12B
Increased by 13.03%
EPS This Year
-0.48
from -5.59
EPS Next Year
0.51
from -0.48
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.2B | 3.7B | 4.2B | ||
| Avg | 3.1B | 3.5B | 3.9B | ||
| Low | 3.0B | 3.3B | 3.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.9% | 19.8% | 18.6% | ||
| Avg | 13.0% | 13.0% | 11.5% | ||
| Low | 8.0% | 5.7% | 0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.81 | 2.05 | 3.49 | ||
| Avg | -0.48 | 0.51 | 1.30 | ||
| Low | -2.15 | -0.36 | -0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 587.4% | ||
| Avg | - | - | 155.6% | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.